Synergy Investment Management’s ResMed RMD Stock Holding History

Synergy Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$898	–	1170
2026 Q1	$898	Buy	+4	New	+$997	﹤0.01%	778

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Synergy Investment Management's RMD Position: Q2 2026 in Review

Synergy Investment Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 4 shares — an estimated $898 sold.

Synergy Investment Management first reported a position in RMD in Q1 2026 and held it in 1 quarter. The position peaked at $898 in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Synergy Investment Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Synergy Investment Management sold 4 ResMed shares in Q2 2026, an estimated $898.
Synergy Investment Management first reported a position in ResMed in Q1 2026 and held it in 1 quarter.
Synergy Investment Management's ResMed position peaked at $898 in Q1 2026.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Synergy Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.